Effects of morphine and naltrexone on impulsive decision making in rats

Authors: Kieres, Artur1; Hausknecht, Kathryn1; Farrar, Andrew1; Acheson, Ashley1; Wit, Harriet2; Richards, Jerry3

Source: Psychopharmacology, Volume 173, Numbers 1-2, April 2004 , pp. 167-174(8)

Publisher: Springer

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

It has been reported that human opiate addicts discount delayed rewards more than non-addicts, indicating that they are more impulsive. However, it is not clear whether this difference reflects pre-existing traits, or the effects of exposure to the opiates.

This study was designed to investigate the effects of an opioid agonist and antagonist on delay discounting in rats. The study had three objectives: to determine (1) the acute effects of the opioid agonist morphine (MOR) on delay discounting, (2) the acute effects of the opioid antagonist naltrexone (NAL) on delay discounting, and (3) whether NAL reverses the effects of MOR on delay discounting.

An adjusting amount procedure (AdjAmt) was used to determine how much animals discounted the value of delayed rewards. Acute doses of MOR (0.3, 1.0, and 1.8 mg/kg SC), NAL (0.01, 0.1, 1.0, and 10 mg/kg SC) and NAL (0.1 mg/kg SC) prior to MOR (1.8 mg/kg SC) were tested in 15 rats.

MOR dose dependently increased the rate of delay discounting (i.e., made the animals more impulsive). NAL alone had no effect on the value of delayed rewards, but NAL blocked the effects of MOR.

These results suggested that the direct effects of MOR may contribute to the high level of impulsive behavior seen among opiate users.

Keywords: Impulsivity; Delay discounting; Opiates; Choice; Operant; Conditioning

Document Type: Research article

DOI: 10.1007/s00213-003-1697-2

Affiliations: 1: Division of Behavioral Medicine, Farber Hall, Room G56, Building no. 26, University at Buffalo, The State University of New York, 3435 Main Street, Buffalo, NY 14214-3000, USA, 2: Department of Psychiatry, The University of Chicago, MC3077, 5841 S. Maryland Avenue, Chicago, IL 60637, USA, 3: Division of Behavioral Medicine, Farber Hall, Room G56, Building no. 26, University at Buffalo, The State University of New York, 3435 Main Street, Buffalo, NY 14214-3000, USA, Email: JR52@buffalo.edu

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$47.00 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A